Related Experiment Videos
Childhood Guillain-Barré syndrome: clinical presentation, diagnosis, and therapy
1Department of Neurology, Children's Hospital and Harvard Medical School, Bost
Insights
Pediatric neurologic emergencies like ascending flaccid paralysis require prompt evaluation. Childhood Guillain-Barré syndrome is a common cause, with treatment options like plasmapheresis and IV immunoglobulin needing further study in children.
Area of Science:
- Pediatric Neurology
- Neuromuscular Disorders
Background:
- Ascending flaccid paraparesis/quadriparesis in children is a rare neurologic emergency.
- Immediate evaluation and treatment are crucial for pediatric patients.
Observation:
- Differential diagnoses include childhood Guillain-Barré syndrome, acute transverse myelitis, and infantile poliomyelitis.
- Clinical differentiation can be challenging in young children due to limitations in sensory examination.
Findings:
- Most children with Guillain-Barré syndrome experience a generally benign illness, but some require intensive care and mechanical ventilation.
- Controlled multi-institutional studies on plasmapheresis or intravenous immunoglobulin for pediatric Guillain-Barré syndrome are lacking.
Implications:
- Further research is needed to establish evidence-based treatment protocols for pediatric Guillain-Barré syndrome.
- Understanding treatment efficacy in children, mirroring adult success, is critical for improving outcomes.
Abstract:
A rapidly progressive, generally symmetric, ascending flaccid paraparesis or quadriparesis that develops in an infant or child constitutes an uncommon but important pediatric neurologic emergency that requires immediate evaluation and treatment. The differential diagnosis primarily includes acute neuropathies, most commonly the childhood Guillain-Barré syndrome and, rarely, acute transverse myelitis or infantile poliomyelitis. A clinical distinction may be difficult in the younger child in whom detailed sensory examination is not possible. Although most children with Guillain-Barré syndrome usually have a benign and relatively limited clinical illness, some become severely ill, requiring intubation and careful intensive monitoring. To date, no well-controlled multi-institutional studies of treatment with either plasmapheresis or intravenously administered immunoglobulin have been developed in children despite the success of these modalities in adults. A review of the data available using these therapies is included in this study.